Project Chintan

Podiatrists Identify Foot Fat Loss as Side Effect of Weight-Loss Medications

Medical experts report an increase in foot pain among patients using GLP-1 medications like Mounjaro and Ozempic due to the loss of protective fat pads. This reduction in natural cushioning can lead to conditions like metatarsalgia and plantar fasciitis.

· 2 min read
Updated

Key takeaways

  • Rapid weight loss from GLP-1 medications can deplete the protective fat pads on the soles of the feet.
  • The resulting lack of cushioning often leads to metatarsalgia, plantar fasciitis, and general foot fatigue.
  • Medical professionals are seeing an increase in patients requiring orthotics or dermal fillers to manage foot pain after using weight-loss jabs.

What Happened

Medical practitioners are observing a rise in foot-related complications among users of GLP-1 weight-loss medications. This phenomenon, colloquially termed "Ozempic feet," involves the rapid loss of fat on the soles of the feet. Senior foot health practitioner Jatender Chaggar reported a 4 per cent increase in patients experiencing this specific type of fat depletion linked to these medications.

As the fat pads on the heel and ball of the foot diminish, the internal structures lose their natural shock absorption. This physical change increases pressure on the metatarsals and toes, often making walking or wearing certain footwear, such as high heels, painful. While there is no definitive evidence that GLP-1 drugs directly target foot tissue, the systemic fat loss they induce includes the critical cushioning layers of the feet.

Why It Matters

The loss of plantar fat pads can exacerbate or reveal underlying mechanical issues. Dr. Manav Bawa, Medical Director of Time Clinic, notes that this reduction in cushioning may lead to metatarsalgia, characterized by burning or tingling in the ball of the foot, or plantar fasciitis, which causes sharp pain in the heel. The risk is notably higher for individuals already experiencing age-related fat pad migration or hormonal shifts during menopause, which naturally thin the skin and soft tissues.

Key Facts

  • Senior foot health practitioner Jatender Chaggar reports a 4 per cent rise in patients with foot fat loss due to GLP-1 use.
  • Plantar fat pads function as shock absorbers; their reduction increases pressure on the foot's bone structure.
  • Loss of cushioning can result in increased foot fatigue and tenderness when walking on hard surfaces.
  • Available treatments include custom-moulded orthotics, which range in price from approximately £400 for prescription versions.
  • Some patients are opting for dermal fillers, such as Juvéderm, to replaces lost volume in the heel and ball of the foot, with results lasting six to 12 months.

What Happens Next

Experts recommend that patients experiencing foot pain after significant weight loss seek diagnostic assessments from podiatrists. Potential interventions include foot exercises performed twice daily to maintain structure and the use of supportive footwear or trainers designed for high impact. Medical professionals emphasize that while fillers can address volume loss, they do not resolve the underlying biomechanical changes, necessitating a focus on long-term weight stability and proper arch support.

Sources reviewed

Project Chintan independently synthesized and analyzed information cross-checked across the sources listed above.

Related stories